Metabolic syndrome was significantly more prevalent in patients with bipolar disorder than in those with major depressive disorder or in controls, Barbora Silarova, Ph.D., and her coauthors reported.
In a study of 2,431 patients the investigators found that those with bipolar disorder had a significantly higher prevalence of metabolic syndrome, compared with patients with major depressive disorder and nonpsychiatric controls (28.4% vs. 20.2% and 16.5%, respectively; P < .001). This difference was consistent when adjusted for sociodemographic and lifestyle factors, Dr. Silarova and her colleagues said in the paper.
“Clinically, it might be relevant to apply individualized treatment for [bipolar disorder] patients that also includes assessment of metabolic risk factors, psychoeducation, weight loss intervention, and improvement of health-related behaviors,” the authors said.
Read the full article in the Journal of Psychosomatic Research here.